A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
Status:
Completed
Trial end date:
2019-04-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see how much study drug is in the blood of children with
pulmonary arterial hypertension (PAH) after dosing to establish the correct dose for further
clinical research.